Waldencast PLC (NASDAQ:WALD) Short Interest Up 121.7% in July

Waldencast PLC (NASDAQ:WALD) was the recipient of a significant growth in short interest in July. As of July 31st, there was short interest totaling 282,629 shares, a growth of 121.7% from the July 15th total of 127,493 shares. Approximately 0.2% of the shares of the company are short sold. Based on an average daily volume of 392,945 shares, the short-interest ratio is currently 0.7 days.

Hedge Funds Weigh In On Waldencast

Hedge funds have recently bought and sold shares of the company. JPMorgan Chase & Co. increased its holdings in Waldencast by 12.7% during the 3rd quarter. JPMorgan Chase & Co. now owns 57,702 shares of the company’s stock worth $114,000 after acquiring an additional 6,516 shares during the period. Barclays PLC boosted its holdings in Waldencast by 11.0% in the 4th quarter. Barclays PLC now owns 66,337 shares of the company’s stock valued at $125,000 after purchasing an additional 6,587 shares during the period. Rhumbline Advisers grew its position in shares of Waldencast by 15.2% during the 1st quarter. Rhumbline Advisers now owns 61,630 shares of the company’s stock valued at $185,000 after purchasing an additional 8,151 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its position in shares of Waldencast by 57.9% during the 2nd quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 23,130 shares of the company’s stock valued at $57,000 after purchasing an additional 8,485 shares in the last quarter. Finally, Bank of America Corp DE increased its holdings in shares of Waldencast by 32.2% in the first quarter. Bank of America Corp DE now owns 42,676 shares of the company’s stock worth $40,000 after purchasing an additional 10,396 shares during the period. Hedge funds and other institutional investors own 41.97% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of analysts recently commented on WALD shares. Canaccord Genuity Group upped their price target on shares of Waldencast from $2.00 to $3.00 and gave the company a “buy” rating in a research note on Tuesday, June 2nd. Weiss Ratings cut shares of Waldencast from a “sell (d-)” rating to a “sell (e+)” rating in a report on Tuesday, July 28th. Finally, Wall Street Zen upgraded Waldencast to a “hold” rating in a research report on Saturday, May 30th. Two analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus price target of $2.33.

Waldencast Stock Performance

WALD stock opened at $1.35 on Friday. The company has a quick ratio of 0.97, a current ratio of 1.70 and a debt-to-equity ratio of 0.29. Waldencast has a twelve month low of $0.72 and a twelve month high of $3.22. The stock has a 50-day simple moving average of $1.64 and a two-hundred day simple moving average of $1.49.

Waldencast Company Profile

Waldencast plc operates in the beauty and wellness business. The company engages in developing, acquiring, accelerating, and scaling various brands. It provides cosmetic, over-the-counter, and prescription products under the Obagi Medical, Obagi Clinical, and Obagi Professional brands; and a Skintrinsiq device for use in facial treatments that is used by physicians' offices, spas, and aestheticians. The company also offers clean makeup products under the Milk Makeup brand. It sells its products to dermatologists, plastic surgeons, and other physicians who focuses on aesthetic and therapeutic skincare, including physicians on site at medical spas, through its direct sales force, as well as through distribution partners.